Back to Search
Start Over
Delayed-enhancement cardiac magnetic resonance imaging detects disease progression in patients with mitral valve disease and atrial fibrillationCentral MessagePerspective
- Source :
- JTCVS Open, Vol 16, Iss , Pp 292-302 (2023)
- Publication Year :
- 2023
- Publisher :
- Elsevier, 2023.
-
Abstract
- Objectives: The mechanism by which mitral valve (MV) disease leads to atrial fibrillation (AF) remains poorly understood. Delayed-enhancement cardiac magnetic resonance imaging (DE-MRI) has been used to assess left atrial (LA) fibrosis in patients with lone AF before catheter ablation; however, few studies have used DE-MRI to assess MV-induced LA fibrosis in patients with or without AF undergoing MV surgery. Methods: Between March 2018 and September 2022, 38 subjects were enrolled; 15 age-matched controls, 14 patients with lone mitral regurgitation (MR), and 9 patients with MR and AF (MR + AF). Indexed LA volume, total LA wall, and regional LA posterior wall (LAPW) enhancement were defined by the DE-MRI. One-way analysis of variance was performed. Results: LA volume and LA enhancement were associated (r = 0.451, P = .004). LA volume differed significantly between controls (37.1 ± 10.6 mL) and patients with lone MR (71.0 ± 35.9, P = .020 and controls and patients with MR + AF (99.3 ± 47.4, P
Details
- Language :
- English
- ISSN :
- 26662736
- Volume :
- 16
- Issue :
- 292-302
- Database :
- Directory of Open Access Journals
- Journal :
- JTCVS Open
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.62f93a8ba86248a79842e74bc952e734
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.xjon.2023.07.024